Clinical Trial Update: Safety and Efficacy of MK-8457 and Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Despite MTX Therapy (P08683, MK-8457-008) [Phase 2]

View source ↗

Summary

A phase 2 trial evaluating safety and efficacy of MK-8457 plus methotrexate in active rheumatoid arthritis patients on MTX was terminated; results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• MK-8457

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Rheumatoid Arthritis (RA) | Phase 2 | Status: TERMINATED | Results posted: 2017-03-09